XML 66 R55.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Subsequent Events (Details) |  |  |  |  |  |  | 6 Months Ended |  |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Aug. 01, 2024 USD ($) shares | Jul. 26, 2024 USD ($) shares | Jul. 22, 2024 USD ($) shares | Jul. 12, 2024 USD ($) | Jul. 01, 2024 kg | Mar. 31, 2022 shares | Jun. 30, 2024 shares | Aug. 02, 2024 USD ($) $ / shares | Jul. 24, 2024 USD ($) | May 12, 2024 shares | Feb. 29, 2024 $ / shares | Feb. 14, 2024 $ / shares | Dec. 31, 2023 shares
Subsequent Events [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of common stock available for issuance |  |  |  |  |  |  |  |  |  |  | 416,667 |  |  |
Price per share | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  | $ 4.5 |
| [1] |  |  |  |  |  |  | 1,017,198 |  |  |  |  |  | 484,187
Converted shares |  |  |  |  |  |  | 92,362 | 6,661 |  |  |  |  |  |
Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsequent Events [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share | $ / shares |  |  |  |  |  |  |  |  |  |  |  | $ 1 |  |
Subsequent Event [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsequent Events [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of stock |  | 677,819 |  |  |  |  |  |  |  |  |  |  |  |
Proceeds for prospectus supplement | $ |  | $ 1,994,583 |  |  |  |  |  |  |  |  |  |  |  |
Castanospermine of kilograms | kg |  |  |  |  |  | 8.8 |  |  |  |  |  |  |  |
Subsequent Event [Member] | At-the-Market Sales Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsequent Events [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of sale | $ |  |  |  |  | $ 15,000,000 |  |  |  |  |  |  |  |  |
Maximum aggregate offering price | $ |  |  | $ 2,190,416 | $ 1,774,640 | 1,253,603 |  |  |  | $ 2,295,192 | $ 1,890,705 |  |  |  |
Subsequent Event [Member] | Knight Therapeutics, Inc. [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsequent Events [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Converted shares |  |  | 33,334 | 40,000 |  |  |  |  |  |  |  |  |  |
Subsequent Event [Member] | WallachBeth Capital LLC [Member] | At-the-Market Sales Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsequent Events [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum aggregate offering price | $ |  |  |  |  | $ 15,000,000 |  |  |  |  |  |  |  |  |
Subsequent Event [Member] | Subsequent Event [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsequent Events [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock meet or exceed per share | $ / shares |  |  |  |  |  |  |  |  | $ 1 |  |  |  |  |
Common Stock [Member] | Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsequent Events [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  | 21,219,937 |  |  |  |  |  |
Common Stock [Member] | Minimum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsequent Events [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  | 1,768,337 |  |  |  |  |  |
Series A Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsequent Events [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Converted shares |  |  |  |  |  |  | 80,965 |  |  |  |  |  |  |
Series A Preferred Stock [Member] | Subsequent Event [Member] | Knight Therapeutics, Inc. [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsequent Events [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Converted shares |  |  | 1,032 | 1,291 |  |  |  |  |  |  |  |  |  |
[1] | Periods presented have been adjusted to reflect the 1:12 reverse stock split on August 12, 2024. See Note 12 - Subsequent Events for more information.

X
- Definition Common stock meet or exceed per share. + References No definition available. + Details
Name: | sxtp_CommonStockMeetOrExceedPerShare
Namespace Prefix: | sxtp_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of maximum aggregate offering price. + References No definition available. + Details
Name: | sxtp_MaximumAggregateOfferingPrice
Namespace Prefix: | sxtp_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of Kilograms of Castanospermine. + References No definition available. + Details
Name: | sxtp_NumberOfKilogramsOfCastanospermine
Namespace Prefix: | sxtp_
Data Type: | dtr:weightItemType
Balance Type: | na
Period Type: | duration

X
- Definition Aggregate number of common shares reserved for future issuance. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockCapitalSharesReservedForFutureIssuance
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.6-05(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(16)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 + Details
Name: | us-gaap_CommonStockSharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5 + Details
Name: | us-gaap_ConversionOfStockSharesConverted1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 + Details
Name: | us-gaap_ProceedsFromIssuanceOrSaleOfEquity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 855 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2 + Details
Name: | us-gaap_SubsequentEventLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sxtp_AgreementAxis=sxtp_AttheMarketSalesAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=sxtp_KnightTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=sxtp_WallachBethCapitalLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsegmentsAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |